Current management of DCIS: a review Neill PataniBruno CutuliKefah Mokbel Review 28 September 2007 Pages: 1 - 10
Old masters as clinical photographers: multifocal breast cancer diagnosed 400 years ago Juan J. GrauTeresa Estrach Invited Commentary 27 September 2007 Pages: 11 - 13
Trichostatin A and 5 Aza-2′ deoxycytidine decrease estrogen receptor mRNA stability in ER positive MCF7 cells through modulation of HuR Peter PryzbylkowskiOluwakemi ObajimiJudith Clancy Keen Preclinical Study 21 September 2007 Pages: 15 - 25
Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients David S. P. TanCaterina MarchióJorge S. Reis-Filho Preclinical Study 06 October 2007 Pages: 27 - 44
Progesterone receptor B (PRB) promoter hypermethylation in sporadic breast cancer Orla Mc CormackWen Y. ChungMichael J. Kerin Preclinical Study 26 September 2007 Pages: 45 - 53
A comparative study of genome-wide SNP, CGH microarray and protein expression analysis to explore genotypic and phenotypic mechanisms of acquired antiestrogen resistance in breast cancer Neil JohnsonValerie SpeirsAndrew G. Hall Preclinical Study 28 September 2007 Pages: 55 - 63
Identification of the functional role of AF1Q in the progression of breast cancer Xin-Zhong ChangDa-Qiang LiZhi-Ming Shao Preclinical Study 11 October 2007 Pages: 65 - 78
Insulin receptor substrate-1 involvement in epidermal growth factor receptor and insulin-like growth factor receptor signalling: implication for Gefitinib (‘Iressa’) response and resistance Janice M. KnowldenHelen E. JonesIain R. Hutcheson Preclinical Study 28 September 2007 Pages: 79 - 91
Polymorphisms in manganese superoxide dismutase, myeloperoxidase and glutathione-S-transferase and survival after treatment for metastatic breast cancer Mary A. BewickMichael S. C. ConlonRobert M. Lafrenie Preclinical Study 07 October 2007 Pages: 93 - 101
MAZ drives tumor-specific expression of PPAR gamma 1 in breast cancer cells Xin WangR. Chase SouthardMichael W. Kilgore Preclinical Study 28 September 2007 Pages: 103 - 111
Estrogen receptor α, BRCA1, and FANCF promoter methylation occur in distinct subsets of sporadic breast cancers Minjie WeiJinhua XuOlufunmilayo I. Olopade Preclinical Study 12 October 2007 Pages: 113 - 120
Histologic grading is an independent prognostic factor in invasive lobular carcinoma of the breast Emad A. RakhaMaysa E. El-SayedIan O. Ellis Preclinical Study 11 October 2007 Pages: 121 - 127
Efficacy of three potent steroid sulfatase inhibitors: pre-clinical investigations for their use in the treatment of hormone-dependent breast cancer Paul A. FosterSurinder K. ChanderAtul Purohit Preclinical Study 04 October 2007 Pages: 129 - 138
The CASP8 -652 6N del promoter polymorphism and breast cancer risk: a multicenter study Bernd FrankSushila H. RigasBarbara Burwinkel Epidemiology 21 September 2007 Pages: 139 - 144
Polymorphism of cytosolic serine hydroxymethyltransferase, estrogen and breast cancer risk among Chinese women in Taiwan Chun-Wen ChengJyh-Cherng YuChen-Yang Shen Epidemiology 22 September 2007 Pages: 145 - 155
Association of polymorphisms of angiogenesis genes with breast cancer Bryan P. SchneiderMilan RadovichDavid A. Flockhart Epidemiology 20 September 2007 Pages: 157 - 163
Modification of risk for subsequent cancer after female breast cancer by a family history of breast cancer Kari HemminkiHui ZhangJusto Lorenzo Bermejo Epidemiology 27 September 2007 Pages: 165 - 169
The CYP1B1_1358_GG genotype is associated with estrogen receptor-negative breast cancer Christina JustenhovenChristiane B. PierlHiltrud Brauch Epidemiology 06 October 2007 Pages: 171 - 177
Influence of preoperative MRI on the surgical management of patients with operable breast cancer Michael BraunMartin PölcherChristiane K. Kuhl Clinical Trial 29 September 2007 Pages: 179 - 187
Medical cost-offsets from psychosocial care in breast cancer Louisa GordonMonika Janda Letter to the Editor 20 September 2007 Pages: 189 - 190
